MRNS
Marinus Pharmaceuticals, Inc
MRNS
MRNS
Delisted
MRNS was delisted on the 10th of February, 2025.
73 hedge funds and large institutions have $139M invested in Marinus Pharmaceuticals, Inc in 2022 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding in top 10
Funds holding in top 10: →
51% less capital invested
Capital invested by funds: $280M → $139M (-$142M)
51% less call options, than puts
Call options by funds: $425K | Put options by funds: $876K
Holders
73
Holding in Top 10
1
Calls
$425K
Puts
$876K
Top Buyers
| 1 | +$3.6M | |
| 2 | +$1.86M | |
| 3 | +$1.34M | |
| 4 |
E
Ergoteles
New York
|
+$945K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$927K |
Top Sellers
| 1 | -$8.15M | |
| 2 | -$2.57M | |
| 3 | -$1.49M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$1.4M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$1.27M |